 CAMBRIDGE, Mass., April 10, 2021 PRNewswire -- Blueprint Medicines Corporation NASDAQ: BPMC today announced data from multiple poster presentations highlighting the breadth of the companys precision therapy pipeline at the virtual American Association for Cancer Research AACR Annual Meeting 2021. 